Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy
Xiaoyan Gao, Tuo Yang, Ying Gu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

The mitophagy pathway and its implications in human diseases
Shouliang Wang, Haijiao Long, Lianjie Hou, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 209
Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Eman E. Alshial, Muhammad Idris Abdulghaney, Al-Hassan Soliman Wadan, et al.
Life Sciences (2023) Vol. 334, pp. 122257-122257
Closed Access | Times Cited: 48
Iron homeostasis imbalance and ferroptosis in brain diseases
Haining Long, Wangshu Zhu, Liming Wei, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 41
Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment
Eui-Hwan Choi, Mi-Hye Kim, Sun-Ji Park
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7952-7952
Open Access | Times Cited: 18
Evolving Landscape of Parkinson’s Disease Research: Challenges and Perspectives
Rumiana Koynova, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Omega (2025) Vol. 10, Iss. 2, pp. 1864-1892
Open Access | Times Cited: 2
The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Viviana A. Ruiz‐Pozo, Rafael Tamayo‐Trujillo, Santiago Cadena-Ullauri, et al.
Nutrients (2023) Vol. 15, Iss. 16, pp. 3585-3585
Open Access | Times Cited: 28
Brain-enriched miR-128: Reduced in exosomes from Parkinson’s patient plasma, improves synaptic integrity, and prevents 6-OHDA mediated neuronal apoptosis
Pallabi Bhattacharyya, Atanu Biswas, Subhas C. Biswas
Frontiers in Cellular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 22
Glial senescence enhances α-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction
Bin Hong, Yosuke Ohtake, Takahide Itokazu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease
Fabio Casciano, Enrico Zauli, Claudio Celeghini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1689-1689
Open Access | Times Cited: 12
Teaghrelin protected dopaminergic neurons in MPTP‐induced Parkinson's disease animal model by promoting PINK1/Parkin‐mediated mitophagy and AMPK/SIRT1/PGC1‐α‐mediated mitochondrial biogenesis
Cian‐Fen Jhuo, Chun‐Jung Chen, Jason T. C. Tzen, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 7, pp. 4022-4034
Closed Access | Times Cited: 12
Parkinson’s Disease and Photobiomodulation: Potential for Treatment
Brian Bicknell, Ann Liebert, Geoffrey Herkes
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 112-112
Open Access | Times Cited: 11
The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain
Jack Jonathan Maran, Moradeke M. Adesina, Colin Green, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101954-101954
Closed Access | Times Cited: 18
Role of F-actin-mediated endocytosis and exercise in mitochondrial transplantation in an experimental Parkinson's disease mouse model
Rachit Jain, Nusrat Begum, Shruti Rajan, et al.
Mitochondrion (2023) Vol. 74, pp. 101824-101824
Open Access | Times Cited: 16
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 73-73
Open Access | Times Cited: 7
A naturally occurring variant of SHLP2 is a protective factor in Parkinson’s disease
Su‐Jeong Kim, Brendan Miller, Nicolas Hartel, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 2, pp. 505-517
Open Access | Times Cited: 6
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
Asif Ahmad Bhat, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 6
Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson's disease in a rat model: Role of PINK-1/PARKIN and PI3K/Akt/CREB/BDNF/TrKB axis
Haneen Y. Khidr, Noha F. Hassan, Sahar S. Abdelrahman, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111207-111207
Closed Access | Times Cited: 15
Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s disease
Ting He, Xiaoyan Lin, Anping Su, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients Using a Multiplatform Mass Spectrometry-Based Metabolomics Approach
Sara Martínez, Oihane E. Albóniga, María Rosa López‐Huertas, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 8, pp. 3025-3040
Closed Access | Times Cited: 5
Spatially resolved multiomics on the neuronal effects induced by spaceflight in mice
Yuvarani Masarapu, Egle Cekanaviciute, Žaneta Andrusivová, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Drosophila melanogaster as a model to study age and sex differences in brain injury and neurodegeneration after mild head trauma
Changtian Ye, Joseph A. Behnke, Katherine R. Hardin, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 12
Inosine attenuates rotenone‐induced Parkinson's disease in rats by alleviating the imbalance between autophagy and apoptosis
Aya M. Abd El‐Latif, Mostafa A. Rabie, Rabab H. Sayed, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1159-1174
Closed Access | Times Cited: 11
Targeting mitochondria with small molecules: A promising strategy for combating Parkinson’s disease
Chinmay Pal
Mitochondrion (2024), pp. 101971-101971
Closed Access | Times Cited: 4
Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson’s Disease
Liyan Shen, Ulf Dettmer
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1649-1649
Open Access | Times Cited: 4
Brain network and energy imbalance in Parkinson’s disease: linking ATP reduction and α-synuclein pathology
Hirohisa Watanabe, Sayuri Shima, Kazuya Kawabata, et al.
Frontiers in Molecular Neuroscience (2025) Vol. 17
Open Access
Page 1 - Next Page

Scroll to top